Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [IR] Samsung Electro-Mechanics (009150) – Q2 2024 Earnings Presentation / 2024-07-31 IR Room
  • [Research] SK hynix (000660 / SKHY) – Eugene Investment | HBM · eSSD · Margin Expansion / 2026-01-30 Research
  • [Research] SK hynix (000660 / SKHY) – Kyobo | Agentic AI · HBM Market Share · Earnings Growth / 2026-07-01 Research
  • [Research] Samsung SDI (006400) – Mirae Asset Securities | Data Center ESS · Potential SDC Monetization · Operating Profit Turnaround / 2026-06-26 Research
  • [Research] Samsung Electro-Mechanics (009150) – Daishin Securities | Supply Shortage · High-End Mix · Earnings Upward Revisions / 2026-07-07 Research
  • [Research] LigaChem Biosciences (141080) – IBK Securities | Enhertu Resistance · Clinical Readouts · Tech Transfer / 2025-11-27 Research
  • [Research] SK hynix (000660 / SKHY) – Shinhan | ADR Listing · HBM Pricing · Valuation Re-rating / 2026-06-30 Research
  • [Research] Samsung Biologics (207940) – Daishin Securities | 4Q Earnings Recovery · New Plant Ramp-up · Peptide Expansion / 2026-07-24 Research

Author: ksb220805@gmail.com

[Research] Celltrion (068270) – IBK Securities | New Biosimilar Mix Expansion · Operating Leverage · H2 Margin Expansion / 2026-05-07

Posted on May 7, 2026August 23, 2026 By ksb220805@gmail.com
[Research] Celltrion (068270) – IBK Securities | New Biosimilar Mix Expansion · Operating Leverage · H2 Margin Expansion / 2026-05-07

Brokerage : IBK Securities Analyst : Lee-soo Jung Investment Rating : BUY (Maintained) Target Price : KRW 250,000 (Maintained) Core Momentum : Expanding sales share of new biosimilar products and operating leverage from top-line growth supporting progressive margin improvements in the second half 📊 1. [Valuation & Key Financial Metrics] 🚀 2. [Market Opportunities &…

Read More “[Research] Celltrion (068270) – IBK Securities | New Biosimilar Mix Expansion · Operating Leverage · H2 Margin Expansion / 2026-05-07” »

Research, Bio & Healthcare

[Research] Celltrion (068270/KS) – SK Securities | New Portfolio Mix Expansion · Operating Leverage · H2 Product Launches / 2026-05-07

Posted on May 7, 2026August 23, 2026 By ksb220805@gmail.com
[Research] Celltrion (068270/KS) – SK Securities | New Portfolio Mix Expansion · Operating Leverage · H2 Product Launches / 2026-05-07

Brokerage : SK Securities Analyst : Seon-kyoung Lee Investment Rating : BUY (Maintained) Target Price : KRW 260,000 (Maintained) Core Momentum : Full-fledged profitability improvement driven by expanding sales mix of new product portfolios and increasing fixed-cost leverage supported by scheduled 2H US launches 📊 1. [Valuation & Key Financial Metrics] 🚀 2. [Market Opportunities…

Read More “[Research] Celltrion (068270/KS) – SK Securities | New Portfolio Mix Expansion · Operating Leverage · H2 Product Launches / 2026-05-07” »

Research, Bio & Healthcare

[Research] Celltrion (068270) – Yuanta Securities | New Biosimilar Growth · Facility Expansion · CMO Capacity Readiness / 2026-05-07

Posted on May 7, 2026August 23, 2026 By ksb220805@gmail.com
[Research] Celltrion (068270) – Yuanta Securities | New Biosimilar Growth · Facility Expansion · CMO Capacity Readiness / 2026-05-07

Brokerage : Yuanta Securities Analyst : Hyun-soo Ha Investment Rating : BUY (Maintained) Target Price : KRW 270,000 (Maintained) Core Momentum : Profitability enhancement driven by an expanding revenue share of new biosimilars, alongside global capacity expansions to support portfolio additions and CMO demand 📊 1. [Valuation & Key Financial Metrics] 🚀 2. [Market Opportunities…

Read More “[Research] Celltrion (068270) – Yuanta Securities | New Biosimilar Growth · Facility Expansion · CMO Capacity Readiness / 2026-05-07” »

Research, Bio & Healthcare

[Research] Celltrion (068270) – DS Investment & Securities | 2nd-Gen Biosimilar Penetration · COGS Ratio Stabilization · Global Capacity Expansion / 2026-05-07

Posted on May 7, 2026August 23, 2026 By ksb220805@gmail.com
[Research] Celltrion (068270) – DS Investment & Securities | 2nd-Gen Biosimilar Penetration · COGS Ratio Stabilization · Global Capacity Expansion / 2026-05-07

Brokerage : DS Investment & Securities Analyst : Min-jeong Kim Investment Rating : BUY (Maintained) Target Price : KRW 320,000 (Maintained) Core Momentum : Rapid commercial penetration of new biosimilars including Omlyclo and Stevqeyma, paired with COGS ratio stabilization, driving solid annual operating profit growth 📊 1. [Valuation & Key Financial Metrics] 🚀 2. [Market…

Read More “[Research] Celltrion (068270) – DS Investment & Securities | 2nd-Gen Biosimilar Penetration · COGS Ratio Stabilization · Global Capacity Expansion / 2026-05-07” »

Research, Bio & Healthcare

[Research] SK hynix (000660 / SKHY) – Mirae Asset | Server CPU Demand · HBM Diversification · HBM4 / 2026-05-07

Posted on May 7, 2026August 24, 2026 By ksb220805@gmail.com
[Research] SK hynix (000660 / SKHY) – Mirae Asset | Server CPU Demand · HBM Diversification · HBM4 / 2026-05-07

Market: KOSPI (000660) Brokerage : Mirae Asset Securities Analyst : Younggun Kim Investment Rating : BUY (Maintained) Target Price : KRW 2,700,000 (Upgraded) Core Momentum : Accelerating server CPU demand from the shift toward inference and agentic AI is expected to expand conventional DRAM demand, while HBM customer diversification and second-half HBM4 shipments support sustained…

Read More “[Research] SK hynix (000660 / SKHY) – Mirae Asset | Server CPU Demand · HBM Diversification · HBM4 / 2026-05-07” »

Research, Semiconductors

[Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | FC-BGA CAPEX Expansion · Price Hikes · 2028F Forward Valuation / 2026-05-06

Posted on May 6, 2026August 24, 2026 By ksb220805@gmail.com
[Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | FC-BGA CAPEX Expansion · Price Hikes · 2028F Forward Valuation / 2026-05-06

Brokerage : Mirae Asset Securities Analyst : Junseo Park (park.junseo@miraeasset.com) Investment Rating : BUY (Maintained) Target Price : KRW 1,300,000 (Raised) Core Momentum : Full-scale earnings expansion and valuation re-rating driven by a ~KRW 3 Trillion FC-BGA CAPEX program backed by client prepayments/price guarantees, +13% FC-BGA ASP increases in 2026, and shifting valuation base to…

Read More “[Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | FC-BGA CAPEX Expansion · Price Hikes · 2028F Forward Valuation / 2026-05-06” »

Research, Semiconductors

[Research] Samsung Electro-Mechanics (009150) – DS Investment & Securities | Price Hikes Ahead · Shortage Cycle · 2027F Peer Multiple / 2026-05-04

Posted on May 4, 2026August 24, 2026 By ksb220805@gmail.com
[Research] Samsung Electro-Mechanics (009150) – DS Investment & Securities | Price Hikes Ahead · Shortage Cycle · 2027F Peer Multiple / 2026-05-04

Brokerage : DS Investment & Securities Analyst : Dae-hyung Cho (dh.cho@ds-sec.co.kr) Investment Rating : BUY Target Price : KRW 1,080,000 (Raised) Core Momentum : Early phase of a structural component shortage cycle, anticipated 2H MLCC price hikes, and simultaneous Q and P expansion in FC-BGA from 2Q Big Tech AI networking shipments driving 2H full…

Read More “[Research] Samsung Electro-Mechanics (009150) – DS Investment & Securities | Price Hikes Ahead · Shortage Cycle · 2027F Peer Multiple / 2026-05-04” »

Research, Semiconductors

[Research] Samsung Electro-Mechanics (009150) – Hana Securities | MLCC & FCBGA Shortage · LTA Expansion · 2027 Peer Multiple / 2026-05-04

Posted on May 4, 2026August 24, 2026 By ksb220805@gmail.com
[Research] Samsung Electro-Mechanics (009150) – Hana Securities | MLCC & FCBGA Shortage · LTA Expansion · 2027 Peer Multiple / 2026-05-04

Brokerage : Hana Securities Analyst : Kim Min-kyung (minkyung.kim@hanafn.com) Investment Rating : BUY (Maintained) Target Price : KRW 1,000,000 (Raised) Core Momentum : Entering a multi-year structural shortage across both MLCCs and FCBGAs driven by AI servers, accelerating customer LTA requests, and closing valuation gaps with global peers via embedded substrates 📊 1. [Valuation &…

Read More “[Research] Samsung Electro-Mechanics (009150) – Hana Securities | MLCC & FCBGA Shortage · LTA Expansion · 2027 Peer Multiple / 2026-05-04” »

Research, Semiconductors

[Research] Samsung Electro-Mechanics (009150) – Yuanta Securities | Dual Growth Engines · 2Q26 OPM Ramp-up · Substrate CapEx Doubling / 2026-05-04

Posted on May 4, 2026August 24, 2026 By ksb220805@gmail.com
[Research] Samsung Electro-Mechanics (009150) – Yuanta Securities | Dual Growth Engines · 2Q26 OPM Ramp-up · Substrate CapEx Doubling / 2026-05-04

Brokerage : Yuanta Securities Analyst : Sunyoung Kou (sunyoung.kou@yuantakorea.com) Investment Rating : BUY (Maintained) Target Price : KRW 1,020,000 (Raised) Core Momentum : Dual earnings growth engines driven by MLCC product mix upgrades and LTA demand visibility alongside a doubling of 2026 FC-BGA CapEx toward 2H26 full capacity utilization 📊 1. [Valuation & Key Financial…

Read More “[Research] Samsung Electro-Mechanics (009150) – Yuanta Securities | Dual Growth Engines · 2Q26 OPM Ramp-up · Substrate CapEx Doubling / 2026-05-04” »

Research, Semiconductors

[Research] Samsung Electro-Mechanics (009150) – Eugene Investment & Securities | AI MLCC · FC-BGA · Product Mix Improvement / 2026-05-04

Posted on May 4, 2026August 24, 2026 By ksb220805@gmail.com
[Research] Samsung Electro-Mechanics (009150) – Eugene Investment & Securities | AI MLCC · FC-BGA · Product Mix Improvement / 2026-05-04

Brokerage : Eugene Investment & Securities Analyst : Lee Joo-hyung Investment Rating : BUY (Maintained) Target Price : KRW 1,030,000 (Raised) Core Momentum : Structural earnings and profitability growth driven by robust order momentum for AI server MLCCs and product mix improvement toward high-margin server/network FC-BGA substrates 📊 1. [Valuation & Key Financial Metrics] 🚀…

Read More “[Research] Samsung Electro-Mechanics (009150) – Eugene Investment & Securities | AI MLCC · FC-BGA · Product Mix Improvement / 2026-05-04” »

Research, Semiconductors

Posts pagination

Previous 1 … 14 15 16 … 31 Next
  • [Research] LIG D&A (079550) – Hana Securities | Complementing Patriot · Cheongung-II Cost Competitiveness · KRW 26.2T Backlog / 2026-03-03 Research
  • [Research] Samsung SDI (006400) – iM Securities | AIDC ESS Demand · US Regulation Benefits · Profit Turnaround / 2026-06-30 Research
  • [Research] SK hynix (000660 / SKHY) – Hana | LPDDR Demand · Mobile DRAM Tightness · Earnings Growth / 2026-04-24 Research
  • [Research] SK hynix (000660 / SKHY) – SK Securities | Supply Tightness · LTA · Shareholder Returns / 2026-07-30 Research
  • [Research] Samsung Biologics (207940) – iM Securities | New Plant Operations · PolyPeptide Acquisition · Portfolio Diversification / 2026-07-24 Research
  • [Research] Samsung SDI (006400) – IBK Securities | Fully Booked North America ESS · Hungarian Utilization Recovery · 4Q26 Turnaround / 2026-04-29 Research
  • [Research] Samsung SDI (006400) – Kiwoom Securities | Near-Term Sluggishness but Intact Momentum · 4Q26 Turnaround · Solid-State Pipeline / 2026-02-03 Research
  • [Research] Alteogen (196170) – Shinhan Securities | 2 Out-Licensing Deals in Q1 · Biogen Deal Analysis · Major Catalysts Ahead from April / 2026-03-27 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme